KORU Medical Systems EBITDA Margin 2010-2025 | KRMD
KORU Medical Systems EBITDA Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
2025-03-31 | $0.04B | $0.00B | -11.43% |
2024-12-31 | $0.03B | $-0.01B | -15.15% |
2024-09-30 | $0.03B | $-0.01B | -19.35% |
2024-06-30 | $0.03B | $-0.01B | -23.33% |
2024-03-31 | $0.03B | $-0.01B | -31.03% |
2023-12-31 | $0.03B | $-0.01B | -35.71% |
2023-09-30 | $0.03B | $-0.01B | -35.71% |
2023-06-30 | $0.03B | $-0.01B | -31.03% |
2023-03-31 | $0.03B | $-0.01B | -31.03% |
2022-12-31 | $0.03B | $-0.01B | -32.14% |
2022-09-30 | $0.03B | $-0.01B | -33.33% |
2022-06-30 | $0.03B | $-0.01B | -36.00% |
2022-03-31 | $0.02B | $-0.01B | -29.17% |
2021-12-31 | $0.02B | $-0.01B | -26.09% |
2021-09-30 | $0.02B | $-0.01B | -23.81% |
2021-06-30 | $0.02B | $0.00B | -19.05% |
2021-03-31 | $0.02B | $0.00B | -17.39% |
2020-12-31 | $0.02B | $0.00B | -4.17% |
2020-09-30 | $0.03B | 0 | 0.00% |
2020-06-30 | $0.03B | $0.00B | 3.70% |
2020-03-31 | $0.02B | $0.00B | 8.33% |
2019-12-31 | $0.02B | $0.00B | 4.35% |
2019-09-30 | $0.02B | $0.00B | 4.76% |
2019-06-30 | $0.02B | $0.00B | 5.26% |
2019-03-31 | $0.02B | $0.00B | 10.53% |
2018-12-31 | $0.02B | $0.00B | 16.67% |
2018-09-30 | $0.02B | $0.00B | 25.00% |
2018-06-30 | $0.02B | $0.00B | 20.00% |
2018-03-31 | $0.01B | $0.00B | 14.29% |
2017-12-31 | $0.01B | $0.00B | 7.14% |
2017-06-30 | $0.01B | 0 | 0.00% |
2017-03-31 | $0.01B | 0 | 0.00% |
2016-11-30 | $0.01B | $0.00B | -8.33% |
2016-09-30 | $0.01B | $0.00B | -16.67% |
2016-06-30 | $0.01B | $0.00B | -11.11% |
2016-05-31 | $0.01B | $0.00B | 11.11% |
2015-08-31 | $0.01B | $0.00B | 11.11% |
2015-05-31 | $0.01B | 0 | 0.00% |
2014-08-31 | $0.01B | $0.00B | 12.50% |
2014-05-31 | $0.01B | $0.00B | 14.29% |
2013-08-31 | $0.01B | 0 | 0.00% |
2013-05-31 | $0.01B | $0.00B | 16.67% |
2012-05-31 | $0.00B | 0 | 0.00% |
2011-12-31 | $0.01B | $0.00B | -20.00% |
2010-06-30 | $0.00B | 0 | 0.00% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.150B | $0.034B |
KORU Medical Systems Inc. is a medical technology company. It focused on development, manufacturing and commercialization of patient-centric large volume subcutaneous infusion solutions. KORU Medical Systems Inc., formerly known as REPRO MEDSYSTEM, is based in MAHWAH, N.J. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $46.064B | 58.60 |
Hims & Hers Health (HIMS) | United States | $13.260B | 137.77 |
Tempus AI (TEM) | United States | $12.137B | 0.00 |
IRhythm Technologies (IRTC) | United States | $4.628B | 0.00 |
Inspire Medical Systems (INSP) | United States | $3.753B | 58.64 |
Hinge Health (HNGE) | United States | $2.965B | 0.00 |
Privia Health (PRVA) | United States | $2.730B | 186.58 |
Enovis (ENOV) | United States | $1.764B | 9.83 |
Schrodinger (SDGR) | United States | $1.532B | 0.00 |
Phreesia (PHR) | United States | $1.519B | 0.00 |
Clover Health Investments (CLOV) | United States | $1.440B | 0.00 |
Azenta (AZTA) | United States | $1.342B | 62.36 |
Omnicell (OMCL) | United States | $1.335B | 23.55 |
10x Genomics (TXG) | United States | $1.300B | 0.00 |
Claritev (CTEV) | United States | $0.661B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.617B | 0.00 |
Butterfly Network (BFLY) | United States | $0.544B | 0.00 |
Talkspace (TALK) | United States | $0.477B | 142.50 |
Veradigm (MDRX) | United States | $0.476B | 0.00 |
Standard BioTools (LAB) | United States | $0.387B | 0.00 |
TruBridge (TBRG) | United States | $0.348B | 771.33 |
Outset Medical (OM) | United States | $0.336B | 0.00 |
Health Catalyst (HCAT) | United States | $0.265B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.264B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.195B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.134B | 0.00 |
Pulmonx (LUNG) | United States | $0.109B | 0.00 |
American Well (AMWL) | United States | $0.104B | 0.00 |
CareCloud (CCLD) | United States | $0.099B | 3.79 |
MDxHealth SA (MDXH) | Belgium | $0.093B | 0.00 |
111 (YI) | China | $0.071B | 0.00 |
HeartBeam (BEAT) | United States | $0.052B | 0.00 |
P3 Health Partners (PIII) | United States | $0.045B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.043B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.033B | 0.00 |
Zhongchao (ZCMD) | China | $0.033B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
Precipio (PRPO) | United States | $0.017B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
Movano (MOVE) | United States | $0.005B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |